Wu, Binbin
Wang, Wei
Zheng, Zhigui
Cao, Sumin
Wang, Xu
Hu, Wenhui
Lin, Boyang
Zhang, Wanggang
Funding for this research was provided by:
Medical and Health Science Program of Zhejiang Province (2025HY0030)
Article History
Received: 17 August 2025
Accepted: 19 August 2026
First Online: 28 August 2026
Declarations
Ethics approval and consent to participate: The study protocol (approval No. 2023‑19G) was approved by the Ethics Committee of Zhejiang Hospital. Written informed consent was obtained from all participants, who were informed of their right to withdraw at any time.
Consent for publication: Not applicable.
Competing interests: Sumin Cao and Xu Wang are employees of Suzhong Pharmaceutical Group Co., Ltd., which sponsored this study. The remaining authors declare no competing interests.